A double-blind, randomized, multicenter, Italian study of frovatriptan versus rizatriptan for the acute treatment of migraine

Author(s):: Savi, L.; Omboni, S.; Lisotto, C.; Zanchin, G.; Ferrari, M.D. (0000-0001-9691-9449); Zava, D.; Pinessi, L.

Published: 2011
Publication type: Article / Letter to editor

MigraineFrovatriptanRizatriptanPatient preference

Date issued: 2011-04-30
Language: English
Is part of: JOURNAL OF HEADACHE AND PAIN (2011), Vol. 12, no. 2, p. 219-226
hdl: 1887/102962
doi: 10.1007/s10194-010-0243-y